JP2008533150A5 - - Google Patents

Download PDF

Info

Publication number
JP2008533150A5
JP2008533150A5 JP2008501942A JP2008501942A JP2008533150A5 JP 2008533150 A5 JP2008533150 A5 JP 2008533150A5 JP 2008501942 A JP2008501942 A JP 2008501942A JP 2008501942 A JP2008501942 A JP 2008501942A JP 2008533150 A5 JP2008533150 A5 JP 2008533150A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
independently
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008501942A
Other languages
English (en)
Japanese (ja)
Other versions
JP5052497B2 (ja
JP2008533150A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/008943 external-priority patent/WO2006101808A1/en
Publication of JP2008533150A publication Critical patent/JP2008533150A/ja
Publication of JP2008533150A5 publication Critical patent/JP2008533150A5/ja
Application granted granted Critical
Publication of JP5052497B2 publication Critical patent/JP5052497B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008501942A 2005-03-17 2006-03-13 ヒスタミンh3受容体アンタゴニストとしてのピロリジン誘導体 Expired - Fee Related JP5052497B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66268605P 2005-03-17 2005-03-17
US60/662,686 2005-03-17
PCT/US2006/008943 WO2006101808A1 (en) 2005-03-17 2006-03-13 Pyrrolidine derivatives as histamine h3 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2008533150A JP2008533150A (ja) 2008-08-21
JP2008533150A5 true JP2008533150A5 (https=) 2012-07-26
JP5052497B2 JP5052497B2 (ja) 2012-10-17

Family

ID=36642817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008501942A Expired - Fee Related JP5052497B2 (ja) 2005-03-17 2006-03-13 ヒスタミンh3受容体アンタゴニストとしてのピロリジン誘導体

Country Status (17)

Country Link
US (1) US7951826B2 (https=)
EP (1) EP1861360B1 (https=)
JP (1) JP5052497B2 (https=)
CN (1) CN101142180B (https=)
AT (1) ATE450503T1 (https=)
AU (1) AU2006227815B2 (https=)
BR (1) BRPI0608523A2 (https=)
CA (1) CA2600757C (https=)
CY (1) CY1109694T1 (https=)
DE (1) DE602006010833D1 (https=)
DK (1) DK1861360T3 (https=)
ES (1) ES2335305T3 (https=)
MX (1) MX2007011374A (https=)
PL (1) PL1861360T3 (https=)
PT (1) PT1861360E (https=)
SI (1) SI1861360T1 (https=)
WO (1) WO2006101808A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008301B2 (en) * 2004-04-01 2011-08-30 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
JP2010529157A (ja) * 2007-06-11 2010-08-26 エフ.ホフマン−ラ ロシュ アーゲー シクロヘキシル誘導体
CN101903340B (zh) 2007-10-17 2013-03-27 赛诺菲-安万特 取代的n-苯基联吡咯烷羧酰胺及其治疗用途
EP2212282B1 (en) 2007-10-17 2011-09-21 Sanofi Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
WO2009052068A1 (en) 2007-10-17 2009-04-23 Sanofi-Aventis Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
CN101903342B (zh) * 2007-10-17 2012-11-21 赛诺菲-安万特 取代的n-苯基-吡咯烷基甲基吡咯烷酰胺及其作为组胺h3受体调节剂的治疗用途
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
CN103242212B (zh) * 2013-05-13 2015-11-04 南京理工大学 一种脑组胺h3受体放射性配体的前体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
US5652258A (en) 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
DK0841922T3 (da) * 1995-05-30 2002-06-03 Gliatech Inc 1H-4(5)-substituerede imidazolderivater
JP2004532834A (ja) * 2001-03-23 2004-10-28 イーライ・リリー・アンド・カンパニー ヒスタミンh3受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用
EP1421071B1 (en) * 2001-07-02 2009-11-18 High Point Pharmaceuticals, LLC Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
GB0224084D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
AU2005252178B2 (en) * 2004-06-02 2011-04-21 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
US7846950B2 (en) * 2004-10-18 2010-12-07 Eli Lilly And Company Histamine H3 receptor inhibitors, preparation and therapeutic uses

Similar Documents

Publication Publication Date Title
JP2008510808A5 (https=)
JP2008500997A5 (https=)
JP2008514655A5 (https=)
JP2008509146A5 (https=)
JP2007534702A5 (https=)
JP2005289914A5 (https=)
RU2007139634A (ru) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
JP2008533150A5 (https=)
JP2014029971A5 (ja) 有機化合物
JP2012140458A5 (https=)
JP2005504811A5 (ja) 置換ペンタセン化合物、半導体デバイス及び物品
JP2008133278A5 (https=)
JP2012140436A5 (ja) 物質
JP2020500178A5 (https=)
EP2177556A3 (en) Silicone for preparing ophthalmic devices
JP2011227454A5 (https=)
JP2009539914A5 (https=)
JP2007519618A5 (https=)
JP2013502441A5 (https=)
JP2005511545A5 (https=)
EP1826196A3 (en) Vinyl ether compounds
JP2008106051A5 (https=)
JP2006527780A5 (https=)
JP2013147490A5 (ja) イリジウム錯体
JP2008500416A5 (https=)